Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:1395-1402
Published online before print September 11, 2006, doi: 10.1161/CIRCULATIONAHA.106.625061
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
114/13/1395    most recent
CIRCULATIONAHA.106.625061v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tao, L.
Right arrow Articles by Ma, X. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tao, L.
Right arrow Articles by Ma, X. L.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Oxidant stress
Right arrow Apoptosis

(Circulation. 2006;114:1395-1402.)
© 2006 American Heart Association, Inc.


Molecular Cardiology

Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis

Ling Tao, MD, PhD; Xiangying Jiao, MD, PhD; Erhe Gao, MD, PhD; Wayne B. Lau, MD; Yuexing Yuan, PhD; Bernard Lopez, MD; Theodore Christopher, MD; Satish P. RamachandraRao, PhD; William Williams, PhD; Garry Southan, PhD; Kumar Sharma, MD; Walter Koch, PhD; Xin L. Ma, MD, PhD

From the Department of Emergency Medicine (L.T., X.J., W.B.L., Y.Y., B.L., T.C., X.L.M.), Center for Translational Medicine (E.G., W.K.), and Division of Nephrology (S.P.R., K.S.), Thomas Jefferson University, Philadelphia, Pa, and Inotek Pharmaceuticals Corporation (W.W., G.S.), Cummings Center, Beverly, Mass.

Correspondence to Xin L Ma, MD, PhD, or Ling Tao, MD, PhD, Department of Emergency Medicine, 1020 Sansom St, Thompson Bldg, Room 239, Philadelphia, PA 19107. E-mail Xin.Ma{at}Jefferson.edu or Ling.Tao@Jefferson.edu

Received March 7, 2006; revision received July 14, 2006; accepted July 21, 2006.

Background— Intracellular proteins involved in oxidative stress and apoptosis are nitrated in diseased tissues but not in normal tissues; definitive evidence to support a causative link between a specific protein that is nitratively modified with tissue injury in a specific disease is limited, however. The aims of the present study were to determine whether thioredoxin (Trx), a novel antioxidant and antiapoptotic molecule, is susceptible to nitrative inactivation and to establish a causative link between Trx nitration and postischemic myocardial apoptosis.

Methods and Results— In vitro exposure of human Trx-1 to 3-morpholinosydnonimine resulted in significant Trx-1 nitration and almost abolished Trx-1 activity. 3-morpholinosydnonimine–induced nitrative Trx-1 inactivation was completely blocked by MnTE-2-PyP5+ (a superoxide dismutase mimetic) and markedly attenuated by PTIO (a nitric oxide scavenger). Administration of either reduced or oxidized Trx-1 in vivo attenuated myocardial ischemia/reperfusion injury (>50% reduction in apoptosis and infarct size, P<0.01). However, administration of nitrated Trx-1 failed to exert a cardioprotective effect. In cardiac tissues obtained from ischemic/reperfused heart, significant Trx-1 nitration was detected, Trx activity was markedly inhibited, Trx-1/ASK1 (apoptosis signal-regulating kinase-1) complex formation was abolished, and apoptosis signal-regulating kinase-1 activity was increased. Treatment with either FP15 (a peroxynitrite decomposition catalyst) or MnTE-2-PyP5+ 10 minutes before reperfusion blocked nitrative Trx inactivation, attenuated apoptosis signal-regulating kinase-1 activation, and reduced postischemic myocardial apoptosis.

Conclusions— These results strongly suggest that nitrative inactivation of Trx plays a proapoptotic role under those pathological conditions in which production of reactive nitrogen species is increased and that antinitrating treatment may have therapeutic value in those diseases, such as myocardial ischemia/reperfusion, in which pathological apoptosis is increased.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y.-M. Go, P. J. Halvey, J. M. Hansen, M. Reed, J. Pohl, and D. P. Jones
Reactive Aldehyde Modification of Thioredoxin-1 Activates Early Steps of Inflammation and Cell Adhesion
Am. J. Pathol., November 1, 2007; 171(5): 1670 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Li, X. Jiao, L. Tao, H. Liu, Y. Cao, B. L. Lopez, T. A. Christopher, and X. L. Ma
Tumor necrosis factor-{alpha} in mechanic trauma plasma mediates cardiomyocyte apoptosis
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1847 - H1852.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Peluffo and R. Radi
Biochemistry of protein tyrosine nitration in cardiovascular pathology
Cardiovasc Res, July 15, 2007; 75(2): 291 - 302.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Shibata, K. Sato, M. Kumada, Y. Izumiya, M. Sonoda, S. Kihara, N. Ouchi, and K. Walsh
Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment
Cardiovasc Res, June 1, 2007; 74(3): 471 - 479.
[Abstract] [Full Text] [PDF]